| COVID-19 Vaccine |
1 |
1 |
| Vaccines |
0 |
0.99 |
| Texas |
0 |
0.73 |
| COVID-19 |
0 |
0.98 |
| Patient Safety |
0 |
0.49 |
| Pregnancy |
0 |
0.34 |
| Bioterrorism |
0 |
0.24 |
| Heart |
0 |
0.24 |
| Pandemic |
0 |
0.97 |
| Severe Acute Respiratory Syndrome |
0 |
0.24 |
| Hospital |
0 |
0.16 |
| Immunization |
0 |
0.96 |
| Pennsylvania |
0 |
0.16 |
| Professional Development |
0 |
0.16 |
| Social Media |
0 |
0.16 |
| Washington |
0 |
0.16 |
| Adverse Effects |
0 |
0.08 |
| Antithrombotics |
0 |
0.08 |
| Board Certification |
0 |
0.08 |
| Corticosteroids |
0 |
0.08 |
| Dorsum |
0 |
0.08 |
| Exercise |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Isolation |
0 |
0.08 |
| Jobs |
0 |
0.08 |
| Medicaid |
0 |
0.08 |
| Medicare |
0 |
0.08 |
| Myocarditis |
0 |
0.08 |
| Thrombosis |
0 |
0.08 |
| Acute Respiratory Distress Syndrome |
0 |
0.07 |
| Cardiomyopathy |
0 |
0.07 |
| Disaster Medicine |
0 |
0.07 |
| Thromboembolism |
0 |
0.07 |
| Toxicology |
0 |
0.07 |
| Revenue and Practice Management |
0 |
0.96 |
| Thrombocytopenia |
0 |
0.02 |